The Fox Focus Spring/Summer 2019 | Page 3

Research Category The True Cost of Parkinson’s An update from our CEO THE ECONOMIC BURDEN STUDY CLEARLY lays out the stakes in Parkinson’s (see cover story). It provides a comprehensive picture of the toll the disease takes. The study shows that Parkinson’s costs our nation over $50 billion a year in direct and indirect expenses. This is nearly doubles previous estimates and includes medical costs like hospitalizations and other ways the disease affects finances, such as missed work days and unpaid care. and identify new drug targets. And at the same time, we support research to measure and treat the causes and symptoms of the disease. The burden of Parkinson’s affects patients, their families and their friends. This is why our mission to cure Parkinson’s is so critical. For a patient, “cure” can mean a lot of things. A drug to stop Parkinson’s from progressing may be a cure. But many patients, including Michael J. Fox, assert that a therapy to effectively treat symptoms over the long term without disabling side effects would be tantamount to a cure in their view. MJFF approaches Parkinson’s research from the most important perspective, that of patients. Our Fox Insight study was created to hear directly from people with Parkinson's and act on what we discover (read more on page 7). In addition, patients told us they needed more and better ways to deal with gait and balance problems. We issued a call for projects and asked patients to review them to make sure they would meet their needs (learn about the grants we awarded on page 5). Since 2014, the U.S. Food and Drug Administration has approved nine new drugs and three devices for Parkinson’s to address serious symptoms of Parkinson’s. Now, with momentum and a growing community of researchers on our side, we have to keep pushing forward. We thank all of you who provide your valuable experiences through Fox Insight and help us in so many other ways. Your generosity is inspiring — from donating to supporting research to volunteering for clinical trials and joining Team Fox — you make success possible. The Michael J. Fox Foundation’s (MJFF) research strategy is focused on accelerating the most innovative ideas to cure Parkinson’s. To do this, we fund research to define the causes of disease Thank you for all you do. How Is MJFF Working to Reduce the Economic Burden? Research is our best chance to reduce economic burden and improve the quality-of-life for Parkinson’s patients and their loved ones. Since January of this year alone, The Michael J. Fox Foundation has awarded more than 165 new grants to researchers around the world, totaling nearly $30 million. All of our funding decisions serve our mission to find a cure for Parkinson’s and improved treatments for those living with the disease today. 3 Spring/Summer The Fox Focus 2019